We accelerate progress by building mutually beneficial clinical trial partnerships that drive more efficient clinical development, acting as an honest broker in wide-ranging collaborations between academic researchers, industry, government and regulators, and patient advocacy organizations.
Partner with QLHC's trial platform and proven site network to accelerate clinical development—from contract execution to first patient first visit in as little as four weeks.
From trial design and consortium leadership to program execution and funding support, QLHC helps investigators and academic partners move from concept to impact with greater speed and efficiency.
Access richly annotated I-SPY data and specimens through a secure discovery platform built to operationalize and analyze one of medicine's most comprehensive multi-modal clinical datasets.
